Page 1 of 4Free preview · 1–4

About this document

A clinical practice review published in Australian Family Physician, volume 37, number 12, December 2008, pages 1002 - 1005. The article discusses vitamin D metabolism, musculoskeletal and nonmusculoskeletal actions, dietary and sunlight sources, deficiency classification, screening, and treatment. It considers how to balance vitamin D requirements with sun protection and reviews emerging research on immune function, cancer, mood, and neurodevelopment.

Free preview text

The first 4 pages, shown as text so search engines and readers can find this document.

Page 1

clinical practice Valerie e Stott MD, MSc, CCFP, is Senior Consultant, Department of Family Medicine, Shaikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. Simon Stilgoe MBChB, LRCP, LRCS, LRCP&S, DipFamMed, is a general practitioner, Booleroo Centre, South Australia. Mark l Stroud MBBS, MPH+TM, DipRACOG, FRACGP, is Senior Consultant, Department of Family Medicine Shaikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. purpose@tpg.com.au Vitamin D A review Historically, vitamin D denoted a constituent of cod liver oil, which cured rickets.1 it also prevented rickets in children and osteomalacia in adults. More recently, other actions of vitamin D have been discovered in addition to its crucial role in calcium homeostasis. Most body tissues have receptors for 1,25[OH]2 vitamin D (calcitriol, 1,25[OH]2D). Vitamin D is produced in the skin or ingested. After hepatic hydroxylation, 25[OH] vitamin D (calcidiol, 25[OH]D) is further hydroxylated in the kidneys to 1,25[OH]2D to exert its endocrine effect on bone, kidneys and intestine. This activated form acts at the cell nucleus (gene upregulation) and cell membrane (rapid response) in over 30 tissues and organs,2 targeting over 200 genes.3 Examples of gene upregulation include the above endocrine actions and additional paracrine actions when tissues, under cytokine control, locally hydroxylate 25[OH]D to 1,25[OH]2D to modulate immune function, cell proliferation and cell differentiation.4,5 Rapid response actions of vitamin D include promoting the intestinal absorption of calcium, the secretion of insulin, the rapid migration of endothelial cells and some osteoblast cell functions.2 the importance of vitamin D Vitamin D is important for muscle and bone health. A prospective population based study in the Netherlands showed increased loss of muscle strength and mass with aging in those with low vitamin D levels.6 Vitamin D deficiency is associated with cortical bone loss,1 increased bone turnover,7 and increased parathyroid hormone levels,5 predisposing to osteoporosis.8 Vitamin D supplementation increases bone density in established deficiency.9 A study in the United Kingdom found vitamin D reduced the risk of fracture in a prospective, randomised, double blinded community based trial.10 An interventional study in Saudi Arabia found a 95% improvement in symptoms related to idiopathic low back pain following treatment with vitamin D.11 Vitamin D deficiency has associations with: • cardiovascular disease12 • insulin resistance and β-cell dysfunction13,14 Background Vitamin D status affects musculoskeletal health. More recently, the nonmusculoskeletal actions of vitamin D have become increasingly documented including endocrine effect on kidneys and intestine, local autocrine effects on cell differentiation, proliferation and immune modulation, and cell membrane effects including promotion of the intestinal absorption of calcium and the secretion of insulin. Objective This article discusses the actions, sources and measurement of vitamin D, and the treatment of established deficiency. It explores what is known about vitamin D, what remains to be discovered, and how clinicians should manage their patients in the interim. Discussion Vitamin D is produced by the same solar radiation that causes skin cancer and aging. Levels in breast milk are low in vitamin depleted breastfeeding women. Despite these realities, there is an opportunity to use existing public health messages to treat the widespread deficiency of vitamin D. 1002 reprinted from auStralian FaMily pHySician Vol. 37, No. 12, December 2008

Page 2

Oula alhabian MD, ABFM, is Senior Consultant, Department of Family Medicine, Shaikh Khalifa Medical City, Abu Dhabi, United Arab Emirates. Khaled Salman MB, BCh, MSc, MD, is Specialist, Department of Family Medicine, Shaikh Khalifa Medical City, Abu Dhabi, United Arab Emirates, and Senior Lecturer, Department of Family Medicine, Suez Canal University, Egypt. • the development of autoimmune disease (including type 1 diabetes, rheumatoid arthritis and multiple sclerosis), and • colon, breast and prostate cancers.4,15 There is experimental evidence in animals that fetal deprivation produced (permanent) neurodevelopmental change16 and in vitro evidence that certain human antimicrobial responses are vitamin D dependent.17 Additionally, a prospective interventional study noted increased mood with vitamin D supplementation,18 and a prospective randomised trial noted a reduced nonskin cancer risk with vitamin D supplementation.19 These associations and results merit further research. Sources of vitamin D Vitamin D is found in two forms: vitamin D3 – c(h)olecalciferol, occurring in humans and animals; and vitamin D2 – ergocalciferol, occurring in plants. Both forms have been commercially synthesised. Dietary sources Food sources include: • fatty fish (eg. herring, mackerel, sardines, tuna, salmon) • eggs, and • fortified foods. Mandatory fortification of margarine and edible oil spreads occurs in Australia. Voluntary fortification of other foods also occurs, however, overall, dietary intake of vitamin D is low. Adequate intake of vitamin D is unlikely to be achieved purely through dietary means, particularly in those at high risk. Table 1 summarises the recommended daily intake of vitamin D. Upper levels of dietary intake are currently 1000 IU/day for infants (0–12 months) and 3200 IU/day for all other ages and for pregnant or lactating women.20 Sunlight exposure The main source of vitamin D is exposure to sunlight. Approximately 90% of vitamin D is obtained this way and most Australians receive their vitamin D requirements from the sun. At comparible latitudes, higher UV levels have been found in the southern hemisphere.20 In many people, adequate sunlight exposure will maintain adequate 25(OH)D serum levels. The skin uses ultraviolet B (UVB) light (280–315 nm wavelength) to form previtamin D3 from 7-dehydrocholesterol (the immediate precursor of cholesterol). Previtamin D3 changes in the skin to vitamin D3, which has a serum half life of 2–3 weeks. Vitamin D3 production in the skin is limited to 10 000–20 000 IU/day.3 Serum levels of 25[OH]D plateau at about 150 nmol/L as UVB inactivates the excess cutaneous previtamin and vitamin.21 Vitamin D binding protein transports vitamin D, the active hormone and its metabolites in the circulation. Skin production of vitamin D depends on: • the amount of UVB energy (eg. latitude, season, time of day, cloud cover) • amount of skin exposed • duration of exposure, and • skin type. Certain medications can increase or decrease 25[OH]D metabolism.22,23 Table 1. Adequate daily dietary intake of vitamin D by age age adequate dietary intake20 Supplementation recommended?20 regular sunlight sufficient?# 0–12 months 200 IU Yes 1–18 years 400 IU Yes 19–50 years 200 IU Possibly 51–70 years 400 IU Possibly not >70 years 600 IU Probably not Institutionalised or housebound elderly Yes, 400–1000 IU No, consider screening Pregnant women 200 IU Consider screening Pregnant women, limited sunlight 400 IU Consider screening Lactating women 200 IU Consider supplementation* Yes, but consider screening* Breastfed child 200 IU Yes Breastfed child at risk (mother dark skinned and/or veiled) Yes, 400 IU for first 12 months Possibly not * Further supplementation may be considered to increase vitamin D content in milk33 # Indicates whether regular sufficient sun exposure is likely to be adequate to maintain vitamin D levels reprinted from auStralian FaMily pHySician Vol. 37, No. 12, December 2008 1003

Page 3

Vitamin D – a reviewclinical practice Screening People at risk of significant deficiency include: • the institutionalised or housebound9 • those with sun avoidant behaviour • refugees24 • those with coeliac disease25 (or other malabsorbtive conditions) • those from areas of high vitamin D deficiency prevalence • those in whom osteoporosis therapy is considered • those with chronic idiopathic musculoskeletal pain, and • pregnant women (particularly if dark skinned or veiled).26 The type of assay is important with different methods giving differing results, particularly at higher serum levels. Liquid chromatography is the criterion standard.15 treatment The current recommended daily intake of vitamin D is adequate for bone health. Our total requirement for vitamin D (sun exposure and dietary intake) is about 4000 IU/day to keep 25(OH)D levels above 100 nmol/L.27 The tolerable upper limit of ingested vitamin D for adults will depend on sun exposure and is currently being debated.28–30 The tolerable upper limit might be as high as 10 000 IU/day, however current recommendations are significantly lower (Table 1). The level of 25[OH]D causing toxicity in healthy adults is also debated but probably occurs at levels >500 nmol/L.28,30 Hypercalciuria occurs before hypercalcemia.1 In Australia, megadose administrations of vitamin D3 have been described,8 including 100 000 IU orally every 4 months10 and 600 000 IU intramuscularly once per year.31 Serum 25[OH]D levels for vitamin D associated with health benefit are listed in Table 3. Treating deficiency involves correcting the vitamin D deficit and ensuring continuing maintenance of vitamin D status. To normalise stores: • adults require 3000–5000 IU/per day for 6–12 weeks9 • children aged <1 month require 1000 IU/day Ultraviolet light also produces skin erythema, sunburn (increasing melanoma risk), and cumulatively, skin aging and increased nonmelanoma skin cancer risk. It is therefore important to give nonconflicting public health messages as we promote healthy behaviours (eg. skin protection, regular physical activity, breastfeeding) and targets (eg. adequate vitamin D levels). For incidental sun exposure (less than half the time required to produce minimal skin erythema) it may be reasonable to omit sunscreen.9 Sunscreen sun protection factor 15 (adequately applied) reduces previtamin D synthesis by >99%.4 Guidelines for adequate sun exposure in Australia are summarised in Table 2. Serum 25[OH]D levels show seasonal fluctuation, with peaks and troughs at the end of summer and winter respectively. At latitudes greater than 35 degrees, UVB energy is insufficient to produce vitamin D during the winter months,4 producing a ‘vitamin D winter’ of variable duration, centered on the winter solstice.3 During these times of no cutaneous vitamin D production, dietary intake of vitamin D and previous vitamin stores become important. Vitamin D deficiency Low 25(OH)D levels are termed ‘hypovitaminosis D’.1 When combined with pathological abnormalities which are corrected by physiological doses of vitamin D, the term ‘vitamin D deficiency’ is used. Significantly low 25(OH)D levels can be termed ‘deficiency’ because of the known abnormal metabolic effects of low vitamin D levels. Rarer conditions exist which require pharmacological doses of vitamin D to overcome either reduced renal 1α-hydroxylase activity or vitamin D receptor resistance. Vitamin D deficiency can be classified as: • mild (25–50 nmol/L) • moderate (12.5–25.0 nmol/L), and • severe (<12.5 nmol/L) with levels of 50–100 nmol/L thought of as being vitamin D insufficient. Table 2. Sun exposure guidelines region October to March april to September At 12:00 At 10:00 or 15:00 At 12:00 At 10:00 or 15:00 North (Townsville and Cairns) 2–5 minutes with extreme care 10 minutes with care 3–10 minutes with care 16 minutes with care Central (Brisbane and Perth) 2–6 minutes with extreme care ~10 minutes with care 4–17 minutes with care 14–44 minutes with care or extreme care in Brisbane South (Adelaide, Sydney, Melbourne, Hobart*) 2–10 minutes with extreme care 15 minutes with extreme care 5–34 minutes with care 21–60 minutes with care Recommended solar radiation exposure to 15% of the body (face, hands, arms) at various times of the day and in various regions of Australia for fair skinned people to produce vitamin D levels equivalent to current recommended daily intakes, assuming exposure occurs 3–4 times per week. Such exposures will give one-third minimal erythema dose, and assumes average solar radiation intensity Fair skinned = Fitzpatrick type II skin; care = sun protection is recommended if exposure is likely to exceed maximum recommended time; extreme care = sun protection is highly recommended, as erythema can occur soon after maximum exposure time is exceeded * Exposure times will be higher in Hobart (see citation for further details) Adapted from: Samanek AJ, Croager EJ, Gies P, et al. Estimates of beneficial and harmful sun exposure times during the year for major Australian population centres. Med J Aust 2006;184:338–41 1004 reprinted from auStralian FaMily pHySician Vol. 37, No. 12, December 2008

Page 4

Vitamin D – a review clinical practice Arabia. Spine 2003;28:177–9. 12. Zittermann A. Vitamin D and disease prevention with special reference to cardio- vascular disease. Prog Biophys Mol Biol 2006;92:39–48. 13. Harkness LS, Bonny AE. Calcium and vitamin D status in the adolescent: key roles for bone, body weight, glucose tolerance, and estrogen biosynthesis. J Pediatr Adolesc Gynaecol 2005;18:305–11. 14. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and b cell dysfunction. Am J Clin Nutr 2004;79:820–5. 15. Schwalfenberg G. Not enough vitamin D – health consequences for Canadians. Can Fam Physician 2007;53:841–54. 16. Feron F, Burne THJ, Brown J, et al. Developmental Vitamin D3 deficiency alters the adult brain. Brain Res Bull 2005;65:141–8. 17. Liu PT, Stenger S, Li H, et.al. Toll-like receptor triggering of vitamin D-mediated human antimicrobial response. Science 2006;311:1770–3. 18. Vieth R, Kimball S, Hu A, Walfish PG. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100mcg (4000 IU) per day on biochemi- cal responses and the wellbeing of patients. Available at www.nutritionj.com/ content/3/1/8 [Accessed 29 April 2008]. 19. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium sup- plementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586–91. 20. Australian NHMRC and New Zealand Ministry of Health. Nutrient values for Australia and New Zealand 2006. Available at www.nrv.gov.au/Nutrients. aspx?code=30178006 [Accessed 3 July 2008]. 21. Binkley N, Novotny D, Krueger T, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 2007;92:2130–5. 22. Agus ZS, Drezner MK. Causes of vitamin D deficiency and resistance. UpToDate 2007. Available at www.utdol.com/utd/content/topic.do?topickey=minmetab/2045 0&view=print [Accessed 8 October 2007]. 23. Aloia JF, Li-Ng M, Pollack S. Statins and vitamin D. Am J Cardiol 2007;100:1329. 24. Benson J. Hiding from the sun: vitamin deficiency in refugees. Aust Fam Physician 2007;36:355–7. 25. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. Gut 2000;46(Suppl I):i1–8. 26. Munns C, Zacharin MR, Rodda CP, et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus state- ment. Med J Aust 2006;185:268–72. 27. Vieth R. Vitamin D supplementation, 25 hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842–56. 28. Vieth R. Critique of the considerations for establishing the tolerable upper intake level for vitamin D: critical need for revision upwards. J Nutr 2006:1117–22. 29. Vieth R. Reply to J Hathcock and I Munro. Am J Clin Nutr 2001;74:862–7. 30. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85:6–18. 31. Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005;183:10–2. 32. Stein M. Vitamin D deficiency. Aust Fam Physician 2007;36:680. 33. Hollis BW, Wagner CL. Vitamin D requirements during lactation: high-dose mater- nal supplementation as therapy to prevent hypovitaminosis D for both the mother and the nursing infant. Am J Clin Nutr 2004;80(Suppl):1752s–8. • children aged 1–12 months require 3000 IU/day, and • children aged >12 months require 5000 IU/day.26 Treatment is for 3 months, with adequate daily calcium. An alternative of 1000 IU, three capsules/tablets three times per day for 1 week then one capsule/tablet per day thereafter, with check of serum 25[OH]D in 5 weeks and attention to adequate calcium intake has been suggested.32 In practice, given the multiple interacting factors, it is appropriate to treat vitamin D deficiency in adults with 2–3 months of supplementation, checking the 25[OH] level and if satisfactory, rechecking the level at the end of winter to ensure the trough is >100 nmol/L.3 The optimal interval between retesting has not been established. Future research The extent to which initial interventional studies, epidemiological associations and experimental studies are replicated will affect future recommended vitamin D intake levels. The use of vitamin D as therapy in infection, cancer and cell regulation is being increasingly explored. The effect of vitamin D on mood and neurodevelopment and in primary cancer prevention is also being studied. Conflict of interest: none declared. references 1. Parfitt AM, Gallagher JC, Heaney RP, et al. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982;36:1014–31. 2. Norman AW. From vitamin D to hormone D: fundamentals of the vitamin D endo- crine system essential for good health. Am J Clin Nutr 2008;88(Suppl):491s–9s. 3. Cannell JJ, Hollis BW, Zasloff M, Heaney RP. Diagnosis and treatment of vitamin D deficiency. Expert Opin Pharmacother 2008;9:107–18. 4. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362–71. 5. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006;92:4–8. 6. Visser M, Deeg D, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 2003; 88:5766–72. 7. Diamond T, Levy S, Smith A, Day P. High bone turnover in Muslim women with vitamin D deficiency. Med J Aust 2002;177:139–41. 8. Megadose therapy for vitamin D deficiency. Med J Aust 2005;183:4–5. 9. Working group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005;182:281–5. 10. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the com- munity: randomized double blind controlled trial. BMJ 2003;326:469–72. 11. Al Faraj SAI, Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Table 3. Levels of 25(OH)D producing health benefit Beneficial effects of vitamin D Minimum serum 25(OH)D required Prevent rickets/osteomalacia3 37.5 nmol/L Dramatically suppress parathyroid hormone levels3 50–75 nmol/L Optimise intestinal calcium absorption3 87 nmol/L Optimise neuromuscular function3,5 60–87 nmol/L Produce sufficient breast milk concentrations for infant health33 110 nmol/L (in one study) Treatment of chronic musculoskeletal pain11 Treat identified deficiency Suggested general target15 >100 nmol/L year round CORRESPONDENCE afp@racgp.org.au reprinted from auStralian FaMily pHySician Vol. 37, No. 12, December 2008 1005

Tags

Doxxly editorial guide

Vitamin D: A review: summary, contents and background

This guide helps you understand the scope of Vitamin D: A review before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.

Summary and overview

Vitamin D: A review is a 4-page documentcredited to Gideon C. Lannister. A clinical practice review published in Australian Family Physician, volume 37, number 12, December 2008, pages 1002 - 1005. The article discusses vitamin D metabolism, musculoskeletal and nonmusculoskeletal actions, dietary and sunlight sources, deficiency classification, screening, and treatment. It considers how to balance vitamin D requirements with sun protection and reviews emerging research on immune function, cancer, mood, and neurodevelopment. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.

The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Vitamin D, Vitamin D deficiency, Clinical practice, Bone health, Nutrition, Sun exposure, Screening, Supplementation, Australia with the related resources linked below.

Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.

Key topics and reader takeaways

The catalogue connects this document with Vitamin D, Vitamin D deficiency, Clinical practice, Bone health, Nutrition, Sun exposure, Screening, Supplementation, Australia. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.

A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.

Table of contents and reading guide

The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 4 pages in the player.

  1. Part 1

    Vitamin D

    Use this section of the reading guide to identify how Vitamin D appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  2. Part 2

    Vitamin D deficiency

    Use this section of the reading guide to identify how Vitamin D deficiency appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  3. Part 3

    Clinical practice

    Use this section of the reading guide to identify how Clinical practice appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  4. Part 4

    Bone health

    Use this section of the reading guide to identify how Bone health appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  5. Part 5

    Nutrition

    Use this section of the reading guide to identify how Nutrition appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  6. Part 6

    Sun exposure

    Use this section of the reading guide to identify how Sun exposure appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  7. Part 7

    Screening

    Use this section of the reading guide to identify how Screening appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

  8. Part 8

    Supplementation

    Use this section of the reading guide to identify how Supplementation appears in Vitamin D: A review, note important terms, and connect the subject to the wider purpose of the work.

When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.

About Gideon C. Lannister

Doxxly credits Gideon C. Lannister as the author or creator of Vitamin D: A review. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.

Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.

About the source organisation

The recorded source for this item is racgp.org.au. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.

Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.

Visit racgp.org.au

How to read and use this document

Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.

The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.

If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.

Research questions to consider

As you read Vitamin D: A review, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.

A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.

Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.

Explore more Medicine & Wellbeing resources

Frequently asked questions about Vitamin D: A review

Practical answers about reading, downloading and understanding this document on Doxxly.

More in Medicine & Wellbeing